Lee, Danner & Bass’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
Other funds holding NWBO
MSAM
VWA
OCG
WJWM
EFG
AA
SL
AMG
KA
Lee, Danner & Bass's NWBO Position: Q4 2024 in Review
Lee, Danner & Bass sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2024, closing a stake of 20,000 shares — an estimated $6K sold.
Lee, Danner & Bass first reported a position in NWBO in Q3 2017 and held it in 28 quarters. The position peaked at $30K in Q1 2021. 11 funds tracked by Wall St. Rank hold NWBO as of Q4 2024.
- Lee, Danner & Bass reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2024 after selling out during the quarter.
- Lee, Danner & Bass sold 20,000 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2024, an estimated $6K.
- Lee, Danner & Bass first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q3 2017 and held it in 28 quarters.
- Lee, Danner & Bass's Northwest Biotherapeutics, Inc. Common stock position peaked at $30K in Q1 2021.
- 11 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2024.
Based on Lee, Danner & Bass's 13F filing for Q4 2024, filed 11 Feb 2025.